Europe's most active early-stage healthtech investor with 75+ portfolio companies. Backs pre-seed to Series A healthtech startups across Europe and the US. Named most active early-stage healthtech investor 2022, 2023, and 2024.
Auto-detected from Calm/Storm Ventures's website.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.